NCT05832502 (PREPARE) is a Phase 2 clinical trial of GBS6 in Group B Streptococcal Infection, sponsored by St George's, University of London.

Who is sponsoring NCT05832502?

NCT05832502 is sponsored by St George's, University of London.

What drugs are being tested in NCT05832502?

Interventions in NCT05832502: GBS6, Placebo.

What condition does NCT05832502 study?

NCT05832502 studies Group B Streptococcal Infection.

Is NCT05832502 still recruiting?

NCT05832502 is currently status unknown. Last updated 16 February 2024.

Last reviewed 2024-02-16 · How we verify

NCT05832502: PREPARE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Trial Investigating the Safety and Immunogenicity of GBS6 in Pregnant Women With and Without HIV (PREPARE)

Status unknown Phase 2 Last updated 16 February 2024

What this trial tests

Phase 2 trial testing GBS6 in Group B Streptococcal Infection in 300 participants. Status unknown.

Timeline

14 October 2022

Primary endpoint
30 September 2025

30 September 2025

Quick facts

Lead sponsor	St George's, University of London
Phase	Phase 2
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	prevention
Enrollment	300
Start date	14 October 2022
Primary completion	30 September 2025
Estimated completion	30 September 2025
Sites	1 location across Uganda

Drugs / interventions tested

GBS6 — full drug profile →
Placebo

Conditions studied

Group B Streptococcal Infection — all drugs for Group B Streptococcal Infection →

Sponsor

St George's, University of London

Who can join

Adults 18 to 40, female only, with Group B Streptococcal Infection. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A placebo controlled clinical trial investigating the safety and immunogenicity of GBS6 in pregnant women with and without human immunodeficiency virus (HIV) infection and their infants

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other St George's, University of London trials

Trials by the same sponsor.

NCT07012421 — Community Antibiotic Use, Susceptibility and ResisTance Among Patients With Urinary Tract Infections (CAST-UTI) · recruiting
NCT06411405 — Using Machine Learning to Model Early-onset Neonatal Sepsis Risk in Uganda and Zimbabwe · unknown
NCT05950984 — Medical Device (MD) Derived Pharmacokinetic (PK) Parameters for Vancomycin (MD-PK) · completed
NCT05855889 — Observational Study of the Management of Infants With Congenital CMV · recruiting
NCT06159218 — Eosinophilic Oesophagitis Assessment With String Testing · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05832502 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by St George's, University of London
Last refreshed: 16 February 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05832502.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing